Currently, the lawsuit is going through a lot of changes. The plaintiff, Sarepta Therapeutics originally filed for a preliminary injunction to force FDA approval of their drug that would allow them to sell it on the market before moving forward with clinical trials that were already in progress. However, this was denied by judge Jed Rakoff who said the court cannot render an order merely because there might be litigation.